Home

SARcode

SARcode is a private, San Francisco based company focused on the development of small molecule LFA-1 inhibitors to treat inflammatory diseases. In December, 2006 SARcode secured $25 million in a financing co-led by Alta Partners and Clarus Ventures.


SARcode News



SARcode Licenses LFA-1 Antagonists from Sunesis Pharmaceuticals (1/4/07)
http://ir.sunesis.com/ReleaseDetail.cfm?ReleaseID=224317

Download PDF

SARcode Reaches Development Milestone (6/5/07)
http://ir.sunesis.com/ReleaseDetail.cfm?ReleaseID=247216

download pdf Download PDF

Contact UsSARcode Corporation
One Embarcadero Center
Suite 2480
San Francisco, CA 94111

SARcode@sarcode.com
SARcode Corporation, Copyright 2008